Evidence map›Paper›PMID 30712150›Full record

ReviewCurrent allergy and asthma reports2019

Asthma and Allergy Mobile Apps in 2018.

Steve Kagen, Amy Garland

Abstract readReview
In one paragraph

Review in Current allergy and asthma reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Clinical inertia in asthma.NPJ primary care respiratory medicine · 2023
    Review
  6. Mobile Health for Asthma.CHEST pulmonary · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Applicability of the MASK-AirInternational journal of molecular sciences · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Nurse Perspectives Regarding Implementation of an Asthma Monitoring Mobile Health Application in the School Setting.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Steve KagenThe Kagen Allergy Clinic, S.C, Appleton, WI, USA. kagensteve@gmail.com.
Amy GarlandThe Kagen Allergy Clinic, S.C, Appleton, WI, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThis paper offers a comprehensive review of interactive mobile allergy and asthma smartphone applications available within the USA in 2018, with an emphasis on interactive asthma apps. RECENT

findingsPrimary care and specialty clinicians interested in introducing digital health apps into their practices will soon have more choices, for Apple® and major electronic medical record software companies are investing heavily in the mobile medical marketplace, guaranteeing personal health information and access to care will always be immediately available in one's digital hand. Interactive mobile asthma applications are valuable assets for patients and caregivers alike, for they offer immediate communications between patients and those responsible for providing for their needs.

Indexed as

AsthmaHumansMobile ApplicationsTelemedicineAllergyAppAsthmaDigital healthmHealthMobile applicationOutcome measuresPeak expiratory flowSmartphoneSymptom score test

Identifiers

PMID30712150
PMCPMC6394463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.